实例探究 > Pioneering precision medicine to diagnose, treat, and prevent neurodegeneration

Pioneering precision medicine to diagnose, treat, and prevent neurodegeneration

公司规模
200-1,000
地区
  • Europe
国家
  • Switzerland
产品
  • SupraAntigen®
  • Morphomer®
  • Benchling
技术栈
  • Cloud-based data management
  • Data visualization
  • Automated data analysis
实施规模
  • Enterprise-wide Deployment
影响指标
  • Digital Expertise
  • Innovation Output
  • Productivity Improvements
技术
  • 应用基础设施与中间件 - 数据交换与集成
  • 应用基础设施与中间件 - 数据可视化
  • 平台即服务 (PaaS) - 数据管理平台
适用行业
  • 医疗保健和医院
  • 生命科学
适用功能
  • 产品研发
  • 质量保证
用例
  • 机器状态监测
  • 预测性维护
服务
  • 云规划/设计/实施服务
  • 数据科学服务
关于客户
AC Immune is a clinical-stage biopharmaceutical company that is leading in precision medicine for neurodegenerative diseases, including Alzheimer’s disease, Parkinson’s disease, and NeuroOrphan indications. The company has two clinically validated technology platforms that fuel its pipeline targeting disease-driving misfolded proteins. The SupraAntigen® platform generates therapeutic vaccines and antibodies with high target specificity, while the Morphomer® platform generates small molecule ligands as therapeutic drugs or brain imaging diagnostic agents. The company aims to shift the treatment paradigm of neurodegenerative disease towards earlier diagnosis and disease prevention. AC Immune is headquartered in Lausanne, Switzerland and has around 150 employees.
挑战
AC Immune, a clinical-stage biopharmaceutical company, was facing challenges in harmonizing data quality and standardization across the company. The R&D teams were using lab notebooks and spreadsheet-based software for data storage, analysis, and sharing, which was time-consuming. The company wanted to speed up crucial handoffs by offering the ability to easily search and interact with data across teams, experiments, and sites. Furthermore, AC Immune was looking for a systematized approach for capturing, sharing, and referencing data to boost data-driven decision-making for cross-functional projects.
解决方案
AC Immune implemented Benchling, a cloud-based data management platform, to improve data capture and quality. The research teams now leverage standardized protocols, workflows, and schemas on Benchling, which strengthens consistency across the organization, leading to better data standardization and searchability. Benchling enables real-time interactions across the company. Since the platform is built for life science research, it boosts collaboration while promoting strong usability and adoption. The platform also provides automated data visualization and reporting features, improving scientific and operational insights while maintaining FAIR (Findable, Accessible, Interoperable and Reusable) data compliance.
运营影响
  • Improved traceability with 93% of users accrediting AC Immune and Benchling collaboration for improving storage, retrieval, and management of historical data and protocols across teams.
  • Saved 4 hours per week per scientist, increasing efficiency of data-sharing with colleagues and reducing time spent on logistical tasks, search, and data compilation.
  • After 6 months, 75% of users said having a unified system enhances their ability to make machine learning models to guide scientific decisions.
数量效益
  • 93% improvement in data traceability.
  • 4 hours saved per week per scientist.
  • 75% of users reported enhanced ability to make machine learning models.

Case Study missing?

Start adding your own!

Register with your work email and create a new case study profile for your business.

Add New Record

相关案例.

联系我们

欢迎与我们交流!
* Required
* Required
* Required
* Invalid email address
提交此表单,即表示您同意 IoT ONE 可以与您联系并分享洞察和营销信息。
不,谢谢,我不想收到来自 IoT ONE 的任何营销电子邮件。
提交

感谢您的信息!
我们会很快与你取得联系。